..

臨床症例報告ジャーナル

原稿を提出する arrow_forward arrow_forward ..

Infant ALK-Positive Anaplastic Large Cell Lymphoma with Unfavourable Prognostic Features and Neutrophilia at Presentation

Abstract

Andrea M Malone, Lorna Storey, Michael McDermot and Owen P Smith

Anaplastic large cell lymphoma (ALCL) is an uncommon form of non-Hodgkin lymphoma in younger patients, accounting for less than 15% of cases. It is exceedingly rare in infants, with a median age at diagnosis of 12 years. Various treatment strategies have been studied in pediatric ALCL, however the long-term event free survival is approximately 70% regardless of treatment approach. We present the case of six month old infant with anaplastic lymphoma kinase (ALK) positive ALCL with unfavourable prognostic features. We elected to treat with upfront brentuximab in addition to combination chemotherapy. This achieved a clinical and molelcular remission of the disease. The treament was well tolerated.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません

この記事をシェアする

インデックス付き

arrow_upward arrow_upward